Home » Stocks » SRGA

Surgalign Holdings, Inc. (SRGA)

Stock Price: $1.86 USD -0.06 (-3.13%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed
After-hours: $1.84 -0.02 (-1.08%) Oct 28, 4:52 PM

Stock Price Chart

Key Info

Market Cap 139.77M
Revenue (ttm) 284.29M
Net Income (ttm) -259.73M
Shares Out 75.15M
EPS (ttm) -3.54
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $1.86
Previous Close $1.92
Change ($) -0.06
Change (%) -3.13%
Day's Open 1.89
Day's Range 1.80 - 1.90
Day's Volume 446,129
52-Week Range 1.46 - 5.40

More Stats

Market Cap 139.77M
Enterprise Value 326.67M
Earnings Date (est) May 6, 2021
Ex-Dividend Date n/a
Shares Outstanding 75.15M
Float 68.52M
EPS (basic) -3.54
EPS (diluted) -3.54
FCF / Share -0.34
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.77M
Short Ratio 3.41
Short % of Float 2.58%
Beta 1.89
PE Ratio n/a
Forward PE 526.32
P/FCF Ratio n/a
PS Ratio 0.49
PB Ratio 12.54
Revenue 284.29M
Operating Income -217.32M
Net Income -259.73M
Free Cash Flow -25.76M
Net Cash -186.89M
Net Cash / Share -2.49
Gross Margin 61.35%
Operating Margin -76.44%
Profit Margin -91.40%
FCF Margin -9.06%
ROA -3.37%
ROE -147.31%
ROIC -91.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(182.26% upside)
Current: $1.86
Target: 5.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth9.99%0%1.58%-2.23%7.41%32.75%11.15%5.2%1.89%-
Gross Profit17114014313315013480.1185.2277.2176.00
Operating Income-182-4.31-4.75-15.2624.635.63-28.6612.2411.77-127
Net Income-212-3.126.91-13.8114.922.70-17.818.408.38-129
Shares Outstanding72.8263.5259.6858.2457.6156.7456.2655.8655.1554.73
Earnings Per Share-2.91-0.080.05-0.300.20-0.01-0.340.150.15-2.36
EPS Growth-------0%--
Operating Cash Flow-9.4617.255.7915.329.006.89-4.4520.8027.7729.39
Capital Expenditures-14.43-11.04-10.48-15.34-17.74-15.58-15.01-11.09-6.35-3.24
Free Cash Flow-23.886.21-4.70-0.01-8.74-8.68-19.479.7121.4226.15
Cash & Equivalents5.6110.9522.3813.8512.6115.7018.7249.7046.1828.21
Total Debt17449.0746.3483.3579.2475.8969.050.120.593.00
Net Cash / Debt-169-38.12-23.96-69.50-66.62-60.19-50.3349.5845.5925.22
Book Value34.56182182165181168168184172162
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Surgalign Holdings, Inc.
Country United States
Employees 935
CEO Terry M. Rich

Stock Information

Ticker Symbol SRGA
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: SRGA
IPO Date August 10, 0200


Surgalign Holdings, a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.